Taken together our results indicate that the combination treatment permits the infiltration of ED1+ CCR2low macrophages, which then differentiate into or promote ED1+ ED2lowMHC II+ smicroglia that favor tumor destruction by creating pro-inflammatory tumor microenvironment. This evidence concerns the gene EDA and neoplasm.